⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses

Official Title: Longitudinal Study of the Effect of Cytoreductive Surgery and HIPEC in Patients With Peritoneal Carcinomatoses

Study ID: NCT04108936

Interventions

Study Description

Brief Summary: Longitudinal Study of the Effect of Cytoreductive Surgery and HIPEC in Patients With Peritoneal Carcinomatoses

Detailed Description: Cross-sectional and longitudinal analysis of cellular immune responses in the context of disease outcome. Cross-sectional and longitudinal analysis of the microbiome in the context of disease outcome. Analysis of renal function with respect of different HIPEC regimens Identification of clinical surrogate parameters for outcome.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Krankenhaus der Barmherzigen Brüder Regensburg, Regensburg, Bavaria, Germany

University Hospital Regensburg, Regensburg, , Germany

Contact Details

Name: Matthias Hornung, MD

Affiliation: Dept. of Surgery, University Hospital Regensburg

Role: STUDY_DIRECTOR

Name: Jens M Werner, MD

Affiliation: Dept. of Surgery, University Hospital Regensburg

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: